Skip to main content

BARCELONA, October 15, 2024 – SpliceBio, a genetic medicines company on a mission to expand the universe of diseases that can be addressed with gene therapy, announced today that it has been awared with “Torres Quevedo 2023” grant from the Spanish Ministry of Science and Innovation.

Leave a Reply